2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosisMike P. Wattjes, Olga Ciccarelli, Daniel S. Reich et al.|The Lancet Neurology|2021Cited by 646
Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosisSergio E. Baranzini, Jorge R. Oksenberg, Joanne Wang et al.|Human Molecular Genetics|2008Cited by 479
Deep gray matter volume loss drives disability worsening in multiple sclerosisArman Eshaghi, Ferrán Prados, Wallace Brownlee et al.|Annals of Neurology|2018Cited by 441
Hippocampal atrophy rates in Alzheimer diseaseWouter J.P. Henneman, Frederik Barkhof, Jasper D. Sluimer et al.|Neurology|2009Cited by 391
Progression of regional grey matter atrophy in multiple sclerosisArman Eshaghi, Olga Ciccarelli, Razvan Marinescu et al.|Brain|2018Cited by 377